# Northern Indiana Cancer Research Consortium IRB – FDA Inspection, Feb 21, 2012

Source: https://www.keypedia.com/records/fda_inspections/northern-indiana-cancer-research-consortium-irb/ec390355-4ab7-448f-9774-1391d4171ee2
Source feed: FDA_Inspections

> FDA inspection 771895 of Northern Indiana Cancer Research Consortium IRB, February 21, 2012. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR part 56. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 771895
- Company Name: Northern Indiana Cancer Research Consortium IRB
- Inspection Date: 2012-02-21
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 854295 - 2013-11-05

Company: https://www.keypedia.com/companies/northern-indiana-cancer-research-consortium-irb/c4163fa0-dc6c-4fa8-b7a0-2df7d8b53b45

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c